Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients Diagnosed With Mild and Severe Cases of COVID19

NCT05160779 is registered in ClinicalTrials.gov with Leonardo Paroche de Matos as lead sponsor.

NCT NCT05160779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05160779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients Diagnosed With Mild and Severe Cases of COVID19
Lead sponsor
Leonardo Paroche de Matos
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2022
Completion date
February 28, 2022
Enrollment
151 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection